Adrenergic beta-receptors having lipolysis property in fat cells is:
## **Core Concept**
Adrenergic beta-receptors play a significant role in lipolysis, which is the breakdown of fats into fatty acids and glycerol. This process is crucial in fat cells (adipocytes). There are several subtypes of beta-adrenergic receptors, including β1, β2, and β3, each having different distributions and effects in the body.
## **Why the Correct Answer is Right**
The correct answer, **β3 (Beta-3) adrenergic receptors**, are predominantly found in adipose tissue. Activation of β3 receptors in fat cells leads to the stimulation of lipolysis. This is achieved through the activation of adenylate cyclase, which increases intracellular cyclic AMP (cAMP) levels. Elevated cAMP activates protein kinase A (PKA), leading to the phosphorylation and activation of hormone-sensitive lipase, the enzyme responsible for the breakdown of triglycerides into fatty acids and glycerol.
## **Why Each Wrong Option is Incorrect**
- **Option A (α1):** α1 adrenergic receptors are primarily involved in smooth muscle contraction and vasoconstriction. They do not play a significant role in lipolysis in fat cells.
- **Option B (β1):** β1 adrenergic receptors are mainly found in the heart, where they mediate increased heart rate and contractility. While they can stimulate adenylate cyclase and increase cAMP, their role in lipolysis is not significant compared to β3 receptors.
- **Option D (β2):** β2 adrenergic receptors are involved in smooth muscle relaxation (e.g., bronchodilation) and have some effect on the heart. They can stimulate lipolysis but are less specific and potent in this effect compared to β3 receptors.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that β3 adrenergic receptors are highly specific to adipose tissue and play a crucial role in regulating lipolysis. This makes β3 receptors an interesting target for drugs aimed at treating obesity. However, the development of β3 agonists as anti-obesity drugs has faced challenges due to side effects and lack of efficacy.
## **Correct Answer:** . β3.